Welcome and Announcements

The COVID-19 Vaccine: Which Populations Are and Should be Prioritized? Will Humble, MPH Executive Director, Arizona Public Health Association - Become familiar with the FDA approval process for SARS CoV2 vaccines
- Understand the types of SARS CoV2 vaccines under development and production in the US
- Be able to identify the population groups that HHS has prioritized for initial vaccine administration and begin to critically think about the merits of their proposal

Break

OIG’s Self-Disclosure Protocol: Benefits, Eligibility, Requirements, and Resolution Matthew Westbrook, Senior Counsel, HHS, OIG, OCIG - Learn the significant benefits to disclosing potential fraud
- Identify the who, what, where, when and why of SDP eligibility
- Know that an internal investigation and - Understand how resolution is reached by cooperation, coordination, and reconciliation

Break

OIG Mandated Six-Year Look Back Audits James Rose, Managing Director, SunHawk Consulting LLC Chad Eckhardt, Partner and Chair - Healthcare Innovation Team, Frost Brown Todd LLC - Use of statistical sampling and extrapolationt
- Recent updates and perspectives
- Drivers of efficient and diligent analysis

Mid-Conference Break

Compliance and Litigation Risks in the Wake of COVID-19 Frank Sheeder, Partner, Alston & Bird LLP - Key risk areas to address
- Preventive measures and practical approaches
- Lessons learned over 2020 and what to expect in 2021

Break

Advocacy in the Age of COVID Elizabeth Lorenz, Director of Policy, Arizona Hospital and Healthcare Association Debbie Johnston, Executive Vice President, Arizona Hospital and Healthcare Association - Understand how public health emergency delcarations impact lawmaking and the regulatory process
- List specific regulatory waivers and executive orders that have been issued during the COVID-19 emergency declaration, and apprehend how these were shapted by advocacy efforts
- Comprehend legal and regulatory issues that remain unsettled within the existing waiver and executive order framework

Break

Compliance Officer Effectiveness During a Pandemic - Never Let a Crisis Go to Waste Cheyenne Ross, Vice President Compliance, P3 Health Partners David Murray, Chief Compliance & Risk Management Officer, Summit Healthcare Kimulet Winzer, Director - Identify the changes that are happening around you, what stakeholders are involved and how is that impacting your core compliance activity e.g. privacy and security, communicating with teams and stakeholders, and continuing work, systems and processes that support needs
- Identify steps to move forward e.g. assessment of risks, making adjustments to policies and procedures, keeping lines of communication open
- Leverage unexpected benefits e.g. generating creative solutions, increased engagement, interacting with new team members in a different way that promotes compliance and achieving business outcomes

Overall Evaluation